270 related articles for article (PubMed ID: 36776869)
1. gC1qR: A New Target for Cancer Immunotherapy.
Lei Y; Li X; Qin D; Zhang Y; Wang Y
Front Immunol; 2023; 14():1095943. PubMed ID: 36776869
[TBL] [Abstract][Full Text] [Related]
2. Complement protein C1q stimulates hyaluronic acid degradation
Balduit A; Vidergar R; Zacchi P; Mangogna A; Agostinis C; Grandolfo M; Bottin C; Salton F; Confalonieri P; Rocca A; Zanconati F; Confalonieri M; Kishore U; Ghebrehiwet B; Bulla R
Front Immunol; 2023; 14():1151194. PubMed ID: 37334363
[TBL] [Abstract][Full Text] [Related]
3. The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.
Ghebrehiwet B; Zaniewski M; Fernandez A; DiGiovanni M; Reyes TN; Ji P; Savitt AG; Williams JL; Seeliger MA; Peerschke EIB
Front Immunol; 2024; 15():1351656. PubMed ID: 38711524
[TBL] [Abstract][Full Text] [Related]
4. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
[TBL] [Abstract][Full Text] [Related]
5. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.
Egusquiza-Alvarez CA; Robles-Flores M
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1831-1854. PubMed ID: 35441886
[TBL] [Abstract][Full Text] [Related]
6. Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma.
Xu J; Sun Y; Jiang J; Xu Z; Li J; Xu T; Liu P
Front Immunol; 2020; 11():1292. PubMed ID: 32760394
[TBL] [Abstract][Full Text] [Related]
7. gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma.
Peerschke E; Stier K; Li X; Kandov E; de Stanchina E; Chang Q; Xiong Y; Manova-Todorova K; Fan N; Barlas A; Ghebrehiwet B; Adusumilli PS
Front Oncol; 2020; 10():1413. PubMed ID: 32903438
[TBL] [Abstract][Full Text] [Related]
8. cC1qR/CR and gC1qR/p33: observations in cancer.
Peerschke EI; Ghebrehiwet B
Mol Immunol; 2014 Oct; 61(2):100-9. PubMed ID: 25044096
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
10. The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells.
Gao LJ; Gu PQ; Fan WM; Liu Z; Qiu F; Peng YZ; Guo XR
Int J Oncol; 2011 Nov; 39(5):1265-72. PubMed ID: 21725590
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
[TBL] [Abstract][Full Text] [Related]
12. Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy.
Li X; Eguchi T; Aly RG; Chintala NK; Tan KS; Zauderer MG; Dembitzer FR; Beasley MB; Ghebrehiwet B; Adusumilli PS; Peerschke EIB
Front Oncol; 2019; 9():1042. PubMed ID: 31681580
[No Abstract] [Full Text] [Related]
13. GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells.
Sünderhauf A; Raschdorf A; Hicken M; Schlichting H; Fetzer F; Brethack AK; Perner S; Kemper C; Ghebrehiwet B; Sina C; Derer S
Front Oncol; 2020; 10():575854. PubMed ID: 33102234
[TBL] [Abstract][Full Text] [Related]
14. Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis.
Kim BC; Hwang HJ; An HT; Lee H; Park JS; Hong J; Ko J; Kim C; Lee JS; Ko YG
Oncotarget; 2016 Aug; 7(31):49972-49985. PubMed ID: 27363031
[TBL] [Abstract][Full Text] [Related]
15. Globular C1q receptor (p33) binds and stabilizes pro-inflammatory MCP-1: a novel mechanism for regulation of MCP-1 production and function.
Anders E; Nebel D; Westman J; Herwald H; Nilsson BO; Svensson D
Biochem J; 2018 Feb; 475(4):775-786. PubMed ID: 29358188
[TBL] [Abstract][Full Text] [Related]
16. Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune function.
Tian H; Wang G; Wang Q; Zhang B; Jiang G; Li H; Chai D; Fang L; Wang M; Zheng J
Cancer Sci; 2022 Mar; 113(3):875-890. PubMed ID: 34978120
[TBL] [Abstract][Full Text] [Related]
17. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway.
Waggoner SN; Cruise MW; Kassel R; Hahn YS
J Immunol; 2005 Oct; 175(7):4706-14. PubMed ID: 16177118
[TBL] [Abstract][Full Text] [Related]
18. Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis.
Kim KB; Yi JS; Nguyen N; Lee JH; Kwon YC; Ahn BY; Cho H; Kim YK; Yoo HJ; Lee JS; Ko YG
J Biol Chem; 2011 Jul; 286(26):23093-101. PubMed ID: 21536672
[TBL] [Abstract][Full Text] [Related]
19. Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis.
Saha P; Datta K
Oncotarget; 2018 Feb; 9(12):10784-10807. PubMed ID: 29535843
[TBL] [Abstract][Full Text] [Related]
20. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.
Ghebrehiwet B; CebadaMora C; Tantral L; Jesty J; Peerschke EI
Adv Exp Med Biol; 2006; 586():95-105. PubMed ID: 16893067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
